OncoSec Medical Inc. To Present At 24th Annual Wall Street Analyst Forum Institutional Investor Conference
2/25/2014 7:19:11 AM
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will present a corporate overview of the company at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference at the University Club in New York, New York on Monday, March 3rd at 12:05 p.m. (EST).
Help employers find you! Check out all the jobs and post your resume.
comments powered by